Login
$MDGL
$423.96 -$3.43 (0.8%) Live

Company Executives

Officer Age 2025 pay Source
Bill Sibold Also a director
President and Chief Executive Officer
59 $19,206,341
William John Sibold
President and CEO
Title from the Form 4 dated Sep 9, 2026
Not stated Not reported
Mardi Dier
Executive Vice President and Chief Financial Officer
62 $6,085,089
Carole Huntsman
Executive Vice President and Chief Commercial Officer
61 $5,441,736
Shannon Kelley
General Counsel
Title from the Form 4 dated Nov 6, 2026
51 $5,179,352
David Soergel
Executive Vice President and Chief Medical Officer
58 $9,190,678

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 28, 2026 · updated by the 8-K of Aug 12, 2026

Directors
10
serving now
Independent
6 of 9
stated in the proxy; 1 not stated
Average tenure
4.8 years
from year joined
CEO also chairs the board
No
Julian C. Baker
Director Age On board Independent Committees Other public boards 2025 pay Source
Julian C. Baker
59 2023
3 years
Independent None stated Incyte Corporation, Acadia Pharmaceuticals, Inc., Denali Therapeutics Inc. $503,397
Bill Sibold
59 2023
3 years
Not independent None stated None stated Paid as CEO
Daniel J. Brennan
60 2025
1 year
Independent None stated Waters Corporation $613,097
Raymond Cheong, M.D., Ph.D.
44 2023
3 years
Independent
Compensation Committee Science and Technology Committee · Chair
vTv Therapeutics Inc. $494,897
James M. Daly
64 2019
7 years
Independent
Audit Committee Nominating and Governance Committee
Acadia Pharmaceuticals, Inc., argenx SE, Cytokinetics Inc. $477,022
Jacqualyn A. Fouse, Ph.D.
64 2025
1 year
Independent
Audit Committee Compensation Committee Nominating and Governance Committee
Incyte, Agios $761,744
Richard S. Levy, M.D.
68 2016
10 years
Independent
Compensation Committee · Chair Nominating and Governance Committee Science and Technology Committee
ProTara Therapeutics, Inc., Kodiak Sciences, Inc., Kiniksa Pharmaceuticals, Ltd. $494,897
Rebecca Taub, M.D.
74 2016
10 years
Not independent None stated BriaCell Therapeutics Corp., Inc. Not stated
Paul A. Friedman, M.D.
Not stated Not stated Not independent
Science and Technology Committee
None stated $469,147
John C. Reed Joined Aug 11, 2026
- - -
Science and Technology Committee
- -

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

No related-party transactions disclosed

The proxy filed Apr 28, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support